Anlotinib
Drug timelines are a Plus or Pro feature.
301 regulatory and trial events tracked for Anlotinib, covering 2015-10-28 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis [Phase 2]